This event is cohosted with ASU’s Future Tense.

This book offers a captivating exploration of how America’s complicated and ever-evolving relationship with the world can be seen through the two footballs of the world—American football and soccer—and the interaction between them.

In the 1970s, an unprecedented wave of international terrorism broke out around the world. More ambitious, networked and far-reaching than ever before, new armed groups terrorized the West with intricately planned plane hijackings and hostage missions, leaving governments scrambling to cope. Their motives were as diverse as their methods. Some sought to champion Palestinian liberation, others to topple Western imperialism or battle capitalism; a few simply sought adventure or power.

Each April, ASU Alumni Association chapters and clubs throughout the nation host local Tillman Honor Runs in support of the Pat Tillman Foundation, honoring the legacy of former Sun Devil and Army Ranger Pat Tillman.

This 4.2-mile fun run is open to all ages and skill levels, providing an opportunity to connect with your community and walk or run for a good cause. This year, participants will receive a 2026 race shirt, medal, ribbon, race bib and exclusive magnet. 

How can federal agencies and policymakers assess the ways in which financial sponsorship shapes the evidence base used to inform regulation, treatment coverage, and public health decision-making? As scientific output grows at an exponential scale, existing oversight tools such as disclosure notices struggle to keep pace with the volume and complexity of potential conflicts of interest in health research.

When 23andMe, a pioneer in direct-to-consumer genetic testing, filed for bankruptcy in March 2025, consumers, state and federal regulators, and policymakers were caught flatfooted over the fate of the sensitive genetic data of some 15 million Americans. As growing volumes of genetic—and increasingly full genomic—data are collected and stored by private firms, this episode underscores the likelihood that similar scenarios will recur across the biotechnology, health data, and digital health sectors.

We are at the beginning of a paradigm shift in biosecurity and biosafety governance. Governments are confronting the limits of reactive, fragmented systems that prioritize performative compliance while offering few ways to measure or improve safety and security outcomes. Companies and universities are caught in a compliance trap but also are eager to responsibly expand biotechnology into domains—including manufacturing and ecosystem management—that fall well outside the original scope of extant oversight.

Etzkowitz and Leydesdorff proposed the triple helical model of innovation (government, industry, and academe) three decades ago. Previously, Vannevar Bush attributed victory in World War II to successful partnerships among the three strands, and proposed that creation of new knowledge through research was a crucial government responsibility. Biomedical research subsequently grew by several orders of magnitude, driven by public investment, transformation of the pharmaceutical and medical device industries, and the emergence of biotechnology.

If the public funds science and gives it autonomy to govern itself, then benefits such as economic growth, innovation, and national security will follow “almost automatically.” This unwritten social contract was long thought to underpin policymakers’ relationship to the scientific enterprise, but the administration’s cuts to science funding and mass federal agency layoffs suggest the pact’s days are over. 

Subscribe to Washington, D.C.